Xeris Biopharma Holdings, Inc. (0A8E.L)

USD 3.29

(-4.76%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 340.79 Million 344.52 Million 344.52 Million 304.36 Million 159.15 Million 120.02 Million
Total Current Assets 156.26 Million 186.81 Million 186.81 Million 142.59 Million 152.21 Million 117.89 Million
Cash And Short Term Investments 72.45 Million 121.96 Million 121.96 Million 102.43 Million 133.78 Million 112.63 Million
Cash and Cash Equivalents 67.44 Million 121.96 Million 121.96 Million 67.27 Million 37.59 Million 45.71 Million
Short Term Investments 5 Million - 35.16 Million 35.16 Million 96.19 Million 66.91 Million
Net Receivables 39.19 Million 30.83 Million 30.83 Million 17.45 Million 6.87 Million 2.86 Million
Inventory 38.83 Million 24.73 Million 24.73 Million 18.11 Million 8.35 Million -
Other Current Assets 5.77 Million 9.28 Million 9.28 Million 4.58 Million 3.19 Million 2.39 Million
Total Non-Current Assets 184.53 Million 157.7 Million 157.7 Million 161.76 Million 6.93 Million 2.12 Million
Net PPE 29.17 Million 28.37 Million 28.37 Million 6.62 Million 6.7 Million 2.03 Million
Good Will And Intangible Assets 132.62 Million 124.59 Million 124.59 Million 154.3 Million - -
Good Will 22.85 Million 120.6 Million 120.6 Million 22.85 Million - -
Intangible Assets 109.76 Million 3.99 Million 3.99 Million 131.45 Million - -
Long-Term Investments 4.22 Million 4.34 Million -364 Thousand - 13.23 Million -
Tax Assets 18.19 Million 115 Thousand 364 Thousand - - -
Other Non Current Assets 315 Thousand 267 Thousand 4.73 Million 829 Thousand -12.99 Million 95 Thousand
Other Assets - - - - - -
Total Liabilities 347.58 Million 299.33 Million 299.33 Million 209.13 Million 125.39 Million 44.62 Million
Total Current Liabilities 95.19 Million 73.62 Million 73.62 Million 79.04 Million 28.2 Million 10.17 Million
Account Payables 11.56 Million 4.6 Million 4.6 Million 8.92 Million 3.11 Million 866 Thousand
Tax Payables - - - - - -
Short Term Debt 3.49 Million 1.58 Million 1.58 Million - - 8.21 Million
Deferred Revenue - 64.77 Million - - - 232 Thousand
Other Current Liabilities 80.13 Million 2.65 Million 67.43 Million 70.11 Million 25.09 Million 860 Thousand
Total Non Current Liabilities 252.38 Million 225.71 Million 225.71 Million 130.09 Million 97.18 Million 34.45 Million
Long-Term Debt 190.93 Million 196.47 Million 196.47 Million 88.06 Million 87.02 Million 31.89 Million
Deferred Revenue Non Current 34.76 Million - - 6.88 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 6.22 Million 25.71 Million 25.71 Million 30.19 Million 10.16 Million 2.56 Million
Other Liabilities - - - - - -
Total Equity -6.78 Million 45.18 Million 45.18 Million 95.23 Million 33.76 Million 75.4 Million
Stock Holders Equity -6.78 Million 45.18 Million 45.18 Million 95.23 Million 33.76 Million 75.4 Million
Common Stock 14 Thousand 14 Thousand 14 Thousand 13 Thousand 6000.00 2000.00
Retained Earnings -617.02 Million -554.77 Million -554.77 Million -460.11 Million -337.38 Million -120.66 Million
Accumulated other comprehensive income -25 Thousand -23 Thousand -23 Thousand -31 Thousand 6000.00 -52 Thousand
Common Stock Equity -6.78 Million 45.18 Million 45.18 Million 95.23 Million 33.76 Million 75.4 Million
Capital Lease Obligation 34.76 Million 10.98 Million 10.98 Million - - -
Total Investments 9.22 Million 4.34 Million 35.16 Million 35.16 Million 96.19 Million 66.91 Million
Total Debt 229.19 Million 198.05 Million 198.05 Million 88.06 Million 87.02 Million 31.89 Million
Net Debt 161.74 Million 76.09 Million 76.09 Million 20.79 Million 49.42 Million -13.82 Million

Balance Sheet Charts